Our previous studies showed that in addition to Bcr-Abl, the JAK2 tryrosine kinase is a key signaling molecule in Bcr-Abl+ CML cells [14, 15, 17, 27, 28]. This evidence concerns the gene JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive.